Phillip M. Gerk
- Obstetrics and Gynecology top 5%
- Pregnancy and preeclampsia studies 6
- Oncology top 10%
- Drug Transport and Resistance Mechanisms 19
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism 4
-
- Pharmacological Effects and Toxicity Studies 6
- Toxicology top 10%
-
- Pregnancy and Medication Impact 7
-
- Diet and metabolism studies 5
-
- Neuropeptides and Animal Physiology 5
-
- Metabolism and Genetic Disorders 4
- Co-authors
- Mary VoreSoniya VaidyaPatrick J. McNamaraAbhishek GulatiAmal AkourMary Jayne KennedyZhenxian ZhangNirmala S. Desai
- Partner nations
- United StatesChinaChile
In The Last Decade
Phillip M. Gerk
51 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 95
- Obstetrics and Gynecology 126
- Oncology 429
- Pharmacology 115
- Pediatrics, Perinatology and Child Health 254
- Toxicology 25
Countries citing papers authored by Phillip M. Gerk
This map shows the geographic impact of Phillip M. Gerk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip M. Gerk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip M. Gerk more than expected).
Fields of papers citing papers by Phillip M. Gerk
This network shows the impact of papers produced by Phillip M. Gerk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip M. Gerk. The network helps show where Phillip M. Gerk may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Phillip M. Gerk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2020 | 27 | |
| 4 | 2020 | 31 | |
| 5 | 2019 | 2 | |
| 6 | 2018 | 1 | |
| 7 | 2016 | 81 | |
| 8 | 2015 | 16 | |
| 9 | 2013 | 32 | |
| 10 | 2013 | 17 | |
| 11 | 2011 | 8 | |
| 12 | 2011 | 9 | |
| 13 | 2011 | 5 | |
| 14 | 2011 | 15 | |
| 15 | 2009 | 24 | |
| 16 | 2007 | 12 | |
| 17 | 2006 | 26 | |
| 18 | 2004 | 25 | |
| 19 | 2003 | 11 | |
| 20 | 2001 | 48 |
About Phillip M. Gerk
Phillip M. Gerk is a scholar working on Pharmacology, Obstetrics and Gynecology and Oncology, having authored 53 papers that have together received 1.2k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (19 papers), Pregnancy and Medication Impact (7 papers), Pregnancy and preeclampsia studies (6 papers), Pharmacological Effects and Toxicity Studies (6 papers), Diet and metabolism studies (5 papers), Neuropeptides and Animal Physiology (5 papers), Metabolism and Genetic Disorders (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). The work is most often cited by research in Obstetrics and Gynecology (126 citations), Oncology (429 citations) and Pharmacology (115 citations). Phillip M. Gerk has collaborated with scholars based in United States, China and Chile. Frequent co-authors include Mary Vore, Soniya Vaidya, Patrick J. McNamara, Abhishek Gulati, Amal Akour, Mary Jayne Kennedy, Zhenxian Zhang, Nirmala S. Desai, Robert J. Kuhn and Jeffrey A. Moscow. Their work appears in journals such as PLoS ONE, Hepatology and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.